Browse
Register
Log In
Variables
505 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec150z26
Possible inferior infarction in stage III
Token «possible inferior infarction in stage III» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150z25
Possible inferior infarction
Token «possible inferior infarction» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150z24
Possible anteroseptal infarction
Token «possible anteroseptal infarction» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150z23
Possible acute anteroseptal infarction
Token «possible acute anteroseptal infarction» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec138d
Positive percentage of T-wave-area, aVR
Positive percentage of T-wave-area in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec138e
Positive percentage of T-wave-area, aVL
Positive percentage of T-wave-area in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec138f
Positive percentage of T-wave-area, aVF
Positive percentage of T-wave-area in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec138l
Positive percentage of T-wave-area, V6
Positive percentage of T-wave-area in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec138k
Positive percentage of T-wave-area, V5
Positive percentage of T-wave-area in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec138j
Positive percentage of T-wave-area, V4
Positive percentage of T-wave-area in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec138i
Positive percentage of T-wave-area, V3
Positive percentage of T-wave-area in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec138h
Positive percentage of T-wave-area, V2
Positive percentage of T-wave-area in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec138g
Positive percentage of T-wave-area, V1
Positive percentage of T-wave-area in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec138c
Positive percentage of T-wave-area, III
Positive percentage of T-wave-area in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec138b
Positive percentage of T-wave-area, II
Positive percentage of T-wave-area in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec138a
Positive percentage of T-wave-area, I
Positive percentage of T-wave-area in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec150v1
Peripheral low voltage
Token «peripheral low voltage» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150w1
Pacemaker EKG
Token «Pacemaker EKG» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec107
PQ-Dispersion
PQ interval dispersion is defined as the difference between the longest and the shortest PQ interval duration measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec108d
PQ Time, aVR
Duration of PQ interval, expressed in milliseconds, measured in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec108e
PQ Time, aVL
Duration of PQ interval, expressed in milliseconds, measured in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec108f
PQ Time, aVF
Duration of PQ interval, expressed in milliseconds, measured in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec108l
PQ Time, V6
Duration of PQ interval, expressed in milliseconds, measured in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec108k
PQ Time, V5
Duration of PQ interval, expressed in milliseconds, measured in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec108j
PQ Time, V4
Duration of PQ interval, expressed in milliseconds, measured in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec108i
PQ Time, V3
Duration of PQ interval, expressed in milliseconds, measured in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec108h
PQ Time, V2
Duration of PQ interval, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec108g
PQ Time, V1
Duration of PQ interval, expressed in milliseconds, measured in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec108c
PQ Time, III
Duration of PQ interval, expressed in milliseconds, measured in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec108b
PQ Time, II
Duration of PQ interval, expressed in milliseconds, measured in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec108a
PQ Time, I
Duration of PQ interval, expressed in milliseconds, measured in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec108
PQ Time
Duration of PQ interval (from the beginning of the P wave to the beginning of the QRS complex), expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec103
P-Dispersion
P wave dispersion is defined as the difference between the longest and the shortest P wave duration measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec105k
P-Amplitude positive, V5
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec105j
P-Amplitude positive, V4
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec105i
P-Amplitude positive, V3
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec105h
P-Amplitude positive, V2
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec105g
P-Amplitude positive, V1
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec105c
P-Amplitude positive, III
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec105b
P-Amplitude positive, II
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec105a
P-Amplitude positive, I
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec106d
P-Amplitude negative, aVR
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec106e
P-Amplitude negative, aVL
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec106f
P-Amplitude negative, aVF
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec106l
P-Amplitude negative, V6
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec106k
P-Amplitude negative, V5
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec106j
P-Amplitude negative, V4
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec106i
P-Amplitude negative, V3
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec106h
P-Amplitude negative, V2
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec106g
P-Amplitude negative, V1
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec106c
P-Amplitude negative, III
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec106b
P-Amplitude negative, II
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec106a
P-Amplitude negative, I
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec150c7
Overturned right type
Token «overturned right type» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150c6
Overturned left type
Token «overturned left type» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ac2
Otherwise normal EKG
Token «otherwise normal EKG» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec148
Original Customed Version
Original version of Custo Software at the time of the ECG exam acquisition
Categorical
ECG 10s (CHRIS baseline)
x0ec150ab11
Note: Channel 'aVL' cannot be measured
Token «Note: Channel 'aVL' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab10
Note: Channel 'aVF' cannot be measured
Token «Note: Channel 'aVF' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab9
Note: Channel 'V5' cannot be measured
Token «Note: Channel 'V5' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab8
Note: Channel 'V4' cannot be measured
Token «Note: Channel 'V4' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab7
Note: Channel 'V3' cannot be measured
Token «Note: Channel 'V3' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab6
Note: Channel 'V2' cannot be measured
Token «Note: Channel 'V2' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab5
Note: Channel 'V1' cannot be measured
Token «Note: Channel 'V1' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab4
Note: Channel 'III' cannot be measured
Token «Note: Channel 'III' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab3
Note: Channel 'II' cannot be measured
Token «Note: Channel 'II' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ab2
Note: Channel 'I' cannot be measured
Token «Note: Channel 'I' cannot be measured» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150a5
Normofrequency sinus rhythm with sinus arrhythmia
Token «normofrequency sinus rhythm with sinus arrhythmia» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150a4
Normofrequency sinus rhythm
Token «normofrequency sinus rhythm» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150c1
Normal type
Token «Normal type» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150ac1
Normal EKG
Token «normal EKG» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150o1
Non-specific broadened P wave
Token «non-specific broadened P wave» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec143d
Noise, aVR
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec143e
Noise, aVL
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec143f
Noise, aVF
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec143l
Noise, V6
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec143k
Noise, V5
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec143j
Noise, V4
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec143i
Noise, V3
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec143h
Noise, V2
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec143g
Noise, V1
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec143c
Noise, III
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec143b
Noise, II
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec143a
Noise, I
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec150ab1
No further interpretation was possible, since no sum complex could be created
Token «No further interpretation was possible, since no sum complex could be created» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec139d
Negative percentage of T-wave-area, aVR
Negative percentage of T-wave-area in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec139e
Negative percentage of T-wave-area, aVL
Negative percentage of T-wave-area in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec139f
Negative percentage of T-wave-area, aVF
Negative percentage of T-wave-area in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec139l
Negative percentage of T-wave-area, V6
Negative percentage of T-wave-area in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec139k
Negative percentage of T-wave-area, V5
Negative percentage of T-wave-area in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec139j
Negative percentage of T-wave-area, V4
Negative percentage of T-wave-area in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec139i
Negative percentage of T-wave-area, V3
Negative percentage of T-wave-area in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec139h
Negative percentage of T-wave-area, V2
Negative percentage of T-wave-area in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec139g
Negative percentage of T-wave-area, V1
Negative percentage of T-wave-area in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec139c
Negative percentage of T-wave-area, III
Negative percentage of T-wave-area in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec139b
Negative percentage of T-wave-area, II
Negative percentage of T-wave-area in lead II
Integer
Previous
1
2
3
4
5
6
Next